0Suppliers
0Customers
1Debt Items
10Related Chains
MBX Biosciences, Inc. Suppliers
No suppliers on recordMBX Biosciences, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.
MBX Biosciences, Inc. Customers
No clients on recordNo downstream customers found in our database for MBX Biosciences, Inc..
MBX Biosciences, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| MBX-DEBT |
Debt stack $555,000 |
90%
|
Market cache reports total debt of $555,000. |
MBX Biosciences, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for MBX Biosciences, Inc..
MBX Biosciences, Inc. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| MBX-OWNER-FRAZIER-LIFE-SCIENCES-MANAGEMENT |
Frazier Life Sciences Management, L.P. |
90%
|
13F overlay lists Frazier Life Sciences Management, L.P. as top holder; 159 tracked holders. |
MBX Biosciences, Inc. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|
| CLDX |
Celldex Therapeutics, Inc. |
100.00 |
2 |
|
| BBIO |
BridgeBio Pharma, Inc. |
100.00 |
2 |
|
| JSPR |
Jasper Therapeutics, Inc. |
100.00 |
2 |
|
| TERN |
Terns Pharmaceuticals, Inc. |
100.00 |
2 |
|
| LLY |
Eli Lilly and Company |
100.00 |
2 |
|
| VKTX |
Viking Therapeutics, Inc. |
100.00 |
2 |
|
| GPCR |
Structure Therapeutics Inc. |
100.00 |
2 |
|
| ORANY |
ORANGE |
50.00 |
2 |
|
| SEPN |
Septerna, Inc. |
36.29 |
1 |
['spend'] |
| VERTEX |
VERTEX |
24.13 |
2 |
|
